BioMab

Milestones

​

Jun. 2012

BioMab, Inc. was founded

 

Dec. 2012

Received the Ministry of Economic Affairs (MOEA) Small Business Innovation Research (SBIR) Phase I grant 

​

Dec. 2015

Received the Subsidies and Incentives Taipei Industry by the Taipei City Government

​

Mar. 2017

Participated in the CANCER-ID Consortium  

​

Jun. 2017

Formed a joint venture with General Biologicals Corporation for GMP production

​

Aug. 2017

Inducted into the National Taiwan University Innovation and Incubation Center

 

Sep. 2017

Received the Ministry of Economic Affairs (MOEA) Small Business Innovation Research (SBIR) Phase II grant

 

Dec. 2017

Signed OEM agreement with OriGene Technologies, Inc. for the global distribution of its monoclonal antibodies product portfolio